Pharmaceuticals are essential to achievehealth outcomes, but are at the same time a major costfactor in every health system. From a patient perspective,access to pharmaceuticals is a proxy for the functioning ofthe health system. With increasing economic strength,patients become more demanding with regard to access tomodern, sophisticated drugs and providers become moreaggressive in marketing those drugs. This paper reflects thesituation in the pharmaceutical sector in Turkey, identifiescritical issues, and discusses policy options based oncurrent trends and the overall policy objectives of theTurkish government. This paper is structured as follows:chapter one gives introduction; chapter two gives overallpolicy objectives in the pharmaceutical sector in Turkey;chapter three presents institutional and regulatoryframework; chapter four presents reimbursement rules;chapter five focuses on governance issues in thepharmaceutical sector; chapter six gives market overview;chapter seven gives payment for pharmaceuticals in Turkey;chapter eight presents prescribing practices - rational useof medicines; and chapter nine gives conclusions and way forward.
PDF
download
878987797
028-85220240
